Moreover, CD40 ligand, a key mediator of T-B cell interactions, holds a dual role as a blood and CSF biomarker of lymphocyte activation linked to MS disease activity [143] and as a promising therapeutic target [144]. Here, CD40LG is linked to myeloid sarcoma.